You May Also Like

Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for use of 7-valent pneumococcal conjugate vaccine (PCV7) in children aged 24-59 months who are not completely vaccinated.
Cite
CITE Title : Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for use of 7-valent pneumococcal conjugate vaccine (PCV7) in children aged 24-59 months who are not completely vaccinated. Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.);United States. Advisory Committee on Immunization Practices.; Published Date : April 4, 2008 Source : MMWR. Morbidity and mortality weekly report. 2008; 57(13):343-4. URL : https://stacks.cdc.gov/view/cdc/7427 Centers for Disease Control and Prevention (U.S.) (2008). Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for use of 7-valent pneumococcal conjugate vaccine (PCV7) in children aged 24-59 months who are not completely vaccinated.. 57(13). Centers for Disease Control and Prevention (U.S.) "Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for use of 7-valent pneumococcal conjugate vaccine (PCV7) in children aged 24-59 months who are not completely vaccinated." 57, no. 13 (2008) Centers for Disease Control and Prevention (U.S.) "Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for use of 7-valent pneumococcal conjugate vaccine (PCV7) in children aged 24-59 months who are not completely vaccinated." vol. 57, no. 13, 2008 Export RIS Citation Information.
Copy Copied Save
Generic APA MLA Chicago RIS
[PDF - 319.43 KB]
:
Centers for Disease Control and Prevention (U.S.) ...
April 4, 2008 | MMWR. Morbidity and mortality weekly report. 2008; 57(13):343-4.
Description:
This notice updates the recommendation for use of 7-valent pneumococcal conjugate vaccine (PCV7) among children aged 24-59 months who are either unvac...
Status:
superseded
File Type:
[PDF - 319.43 KB]
File Type:
[PDF - 319.43 KB]

Revised recommendations of the Advisory Committee on Immunization Practices to Vaccinate all Persons Aged 11-18 Years with Meningococcal Conjugate Vaccine
Cite
CITE Title : Revised recommendations of the Advisory Committee on Immunization Practices to Vaccinate all Persons Aged 11-18 Years with Meningococcal Conjugate Vaccine Corporate Authors(s) : United States. Advisory Committee on Immunization Practices. Published Date : August 10, 2007 Source : MMWR. Morbidity and mortality weekly report. 2007; 56(31):794-5. URL : https://stacks.cdc.gov/view/cdc/7424 United States. Advisory Committee on Immunization Practices. (2007). Revised recommendations of the Advisory Committee on Immunization Practices to Vaccinate all Persons Aged 11-18 Years with Meningococcal Conjugate Vaccine. 56(31). United States. Advisory Committee on Immunization Practices. "Revised recommendations of the Advisory Committee on Immunization Practices to Vaccinate all Persons Aged 11-18 Years with Meningococcal Conjugate Vaccine" 56, no. 31 (2007) United States. Advisory Committee on Immunization Practices. "Revised recommendations of the Advisory Committee on Immunization Practices to Vaccinate all Persons Aged 11-18 Years with Meningococcal Conjugate Vaccine" vol. 56, no. 31, 2007 Export RIS Citation Information.
Copy Copied Save
Generic APA MLA Chicago RIS
[PDF - 515.21 KB]
:
United States. Advisory Committee on Immunization Practices.
August 10, 2007 | MMWR. Morbidity and mortality weekly report. 2007; 56(31):794-5.
Description:
In January 2005, a quadrivalent meningococcal polysaccharide- protein conjugate vaccine (MCV4) (Menactra™, Sanofi Pasteur, Inc., Swiftwater, Pennsyl...
Status:
superseded
File Type:
[PDF - 515.21 KB]
File Type:
[PDF - 515.21 KB]